hahaha.... trust me... I was so close to buy them but my stubbornness not to put few cents higher holded me back.... the mistake I didn't make with Nyrada...
I don't think I can name give HC policies of no cross promotion ...
couple of them are 1) in Chronic Kidney space and now in wonderful Covid opportunity (I think the company is ridiculously undervalued, doubled my money in 4 years despite being so undervalued currently)..
2) in Stem cell space (not MSB)..
I will definitely double my position on Nyrada in next 3-4 months time assuming it doesn't appreciate ...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $62.37M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.0¢ | $277.0K | 957.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 116270 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 130414 | 1 |
View Market Depth
| Last trade - 15.54pm 07/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |